PLOD1 and central precocious puberty: There are only three studies evaluating random LH concentrations or prevalence of increased random LH in CPP patients during GnRHa treatment as the main outcome [one in patients with trimonthly GnRHa injection (7) and the others in patients receiving  annual GnRHa implant (10,11)].